Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E46.68 EPS (ttm)1.99 Insider Own0.70% Shs Outstand1.77B Perf Week0.88%
Market Cap165.69B Forward P/E25.29 EPS next Y3.68 Insider Trans-5.95% Shs Float1.76B Perf Month0.95%
Income3.55B PEG4.54 EPS next Q0.41 Inst Own76.30% Short Float0.73% Perf Quarter8.14%
Sales32.10B P/S5.16 EPS this Y45.20% Inst Trans-0.02% Short Ratio1.69 Perf Half Y7.64%
Book/sh17.08 P/B5.45 EPS next Y29.50% ROA5.30% Target Price101.93 Perf Year8.48%
Cash/sh2.06 P/C45.17 EPS next 5Y10.28% ROE11.50% 52W Range61.61 - 100.00 Perf YTD7.11%
Dividend1.44 P/FCF77.68 EPS past 5Y12.40% ROI8.20% 52W High-6.96% Beta0.96
Dividend %1.55% Quick Ratio1.00 Sales past 5Y9.50% Gross Margin58.50% 52W Low51.01% ATR2.36
Employees107000 Current Ratio1.40 Sales Q/Q2.50% Oper. Margin14.00% RSI (14)55.01 Volatility2.07% 2.63%
OptionableYes Debt/Eq0.60 EPS Q/Q-8.60% Profit Margin11.20% Rel Volume0.38 Prev Close93.67
ShortableYes LT Debt/Eq0.56 EarningsJul 16 BMO Payout65.30% Avg Volume7.60M Price93.04
Recom1.90 SMA202.74% SMA502.05% SMA2008.21% Volume2,920,034 Change-0.67%
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Jul-10-20 12:49PM  
08:00AM  
Jul-09-20 04:07PM  
12:30PM  
11:30AM  
09:32AM  
Jul-08-20 08:48AM  
Jul-07-20 03:42PM  
09:40AM  
Jul-06-20 04:03PM  
07:30AM  
06:31AM  
Jul-04-20 07:32AM  
Jul-02-20 10:31PM  
05:45PM  
05:17PM  
Jun-30-20 05:56PM  
02:31PM  
11:52AM  
Jun-29-20 09:13AM  
09:00AM  
07:47AM  
Jun-26-20 05:45PM  
09:00AM  
Jun-25-20 11:06AM  
10:00AM  
Jun-24-20 05:50PM  
03:49PM  
12:23PM  
Jun-23-20 05:32PM  
09:00AM  
07:19AM  
Jun-22-20 09:15AM  
Jun-18-20 05:45PM  
Jun-17-20 06:18PM  
07:11AM  
Jun-16-20 12:34PM  
09:00AM  
09:00AM  
07:00AM  
12:00AM  
Jun-15-20 05:18PM  
11:59AM  
10:49AM  
10:25AM  
07:59AM  
07:17AM  
07:01AM  
Jun-14-20 06:55AM  
Jun-13-20 11:00AM  
Jun-12-20 05:45PM  
10:28AM  
08:58AM  
Jun-11-20 07:09AM  
06:30AM  
02:00AM  
Jun-09-20 10:13AM  
Jun-07-20 11:22AM  
Jun-06-20 07:41AM  
05:52AM  
Jun-05-20 09:21AM  
Jun-04-20 06:50PM  
11:44AM  
Jun-03-20 12:51PM  
Jun-02-20 05:45PM  
02:05PM  
Jun-01-20 07:07PM  
May-30-20 07:44AM  
May-29-20 06:07PM  
May-28-20 07:01AM  
May-27-20 05:45PM  
May-26-20 11:34PM  
03:23PM  
May-24-20 07:33AM  
06:32AM  
May-22-20 06:11PM  
05:37PM  
12:29PM  
09:45AM  
08:40AM  
07:50AM  
May-21-20 05:45PM  
05:44PM  
04:11PM  
03:18PM  
02:18PM  
12:14PM  
07:00AM  
May-19-20 04:05PM  
07:12AM  
May-18-20 06:16AM  
May-16-20 03:10PM  
11:50AM  
11:48AM  
11:30AM  
May-15-20 06:00PM  
05:56PM  
04:54PM  
04:34PM  
04:00PM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Earnhardt Lisa DExecutive Vice PresidentJun 10Sale90.8487279,21672,074Jun 12 05:07 PM
LANE ANDREW HExecutive Vice PresidentMay 05Option Exercise43.8280,0003,505,314145,822May 07 05:02 PM
LANE ANDREW HExecutive Vice PresidentMay 05Sale92.0080,0007,360,10465,822May 07 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 28Sale93.183,724347,01248,767Apr 30 06:34 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Option Exercise22.3950,1001,121,834366,900Apr 23 09:34 PM
Ginascol John FExecutive Vice PresidentApr 21Option Exercise38.4063,2002,426,880129,645Apr 23 09:41 PM
Funck Robert EExecutive Vice President & CFOApr 21Option Exercise36.4236,7001,336,638206,072Apr 23 09:27 PM
Contreras JaimeSenior Vice PresidentApr 21Option Exercise57.12108,4126,192,995145,431Apr 23 09:26 PM
Ginascol John FExecutive Vice PresidentApr 21Sale96.0063,2006,067,05166,445Apr 23 09:41 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Sale95.8750,1004,803,326316,800Apr 23 09:34 PM
Scoggins Christopher JSenior Vice PresidentApr 21Sale96.1041439,78539,706Apr 23 09:28 PM
Boudreau Philip PVice PresidentMar 13Sale82.0010,600869,20022,463Mar 16 06:47 PM
Watkin JaredSenior Vice PresidentMar 06Sale82.008,248676,33668,696Mar 10 05:06 PM
BIRD ROGERSenior Vice PresidentMar 02Sale77.8966651,87562,920Mar 03 05:23 PM
DALE MICHAEL DSenior Vice PresidentMar 02Sale77.8978761,29934,763Mar 03 05:21 PM
Ginascol John FExecutive Vice PresidentMar 02Sale77.636,606512,80566,445Mar 03 05:20 PM
Contreras JaimeSenior Vice PresidentMar 02Sale77.892,001155,85837,019Mar 03 05:19 PM
Watkin JaredSenior Vice PresidentMar 02Sale77.891,761137,16476,944Mar 03 05:19 PM
ALLEN HUBERT LExecutive Vice PresidentMar 02Sale77.891,20894,091151,896Mar 03 05:16 PM
Scoggins Christopher JSenior Vice PresidentMar 02Sale77.891,24096,58441,168Mar 03 05:15 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 02Sale77.8999977,812103,493Mar 03 05:16 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 02Sale77.891,781138,72245,460Mar 03 05:13 PM
Wainer Andrea FExecutive Vice PresidentMar 02Sale77.891,429111,30549,498Mar 03 05:10 PM
Funck Robert EExecutive Vice President & CFOMar 02Sale77.891,356105,619169,372Mar 03 05:28 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentMar 02Sale77.891,420110,60453,859Mar 03 05:27 PM
Moreland Mary KExecutive Vice PresidentFeb 25Sale84.9340033,97266,131Feb 25 05:29 PM
Moreland Mary KExecutive Vice PresidentFeb 19Sale88.971,01990,66052,985Feb 19 05:53 PM
DALE MICHAEL DSenior Vice PresidentFeb 19Sale88.9739635,23223,947Feb 19 05:53 PM
Wainer Andrea FExecutive Vice PresidentFeb 07Sale88.611,12099,24540,140Feb 11 06:10 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Option Exercise45.33509,85023,110,674624,231Jan 30 05:23 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Sale89.73509,85045,747,209114,381Jan 30 05:23 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Option Exercise38.4037,5001,440,00088,032Jan 29 05:06 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Sale89.5837,5003,359,41150,534Jan 29 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Option Exercise38.4016,000614,40068,562Oct 25 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Sale80.5421,0001,691,31547,562Oct 25 05:02 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Option Exercise47.0047,2262,219,62297,755Sep 04 05:20 PM
MANNING JOSEPH JSenior Vice PresidentAug 30Sale85.1447,2264,020,68550,532Sep 04 05:20 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Option Exercise50.7223,0081,166,966104,228Aug 13 07:12 PM
Funck Robert ESenior Vice PresidentAug 09Option Exercise34.9440,0001,397,600178,991Aug 13 07:11 PM
PEDERSON MICHAEL JSenior Vice PresidentAug 09Sale86.3923,0081,987,70581,220Aug 13 07:12 PM
YOOR BRIAN BExecutive Vice President & CFOAug 08Option Exercise38.0343,7631,664,357158,144Aug 09 05:05 PM
YOOR BRIAN BExecutive Vice President & CFOAug 08Sale85.7743,7633,753,706114,381Aug 09 05:05 PM
Blount Sally E.DirectorJul 31Sale87.652,500219,12126,266Aug 02 05:01 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentJul 24Option Exercise38.4065,0002,496,000117,562Jul 26 09:30 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentJul 24Sale88.0165,0005,720,32552,562Jul 26 09:30 PM